MAIA Biotechnology Inc.
Stock Chart, Company Information, and Scan Results
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
MAIA Biotechnology Inc. Company Information, Fundamentals, and Technical Indicators
MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
MAIA Biotechnology Inc. In Our Stock Scanner
As of Nov 19, 2025Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.